Hashimoto's Thyroiditis and the Risk of Papillary Thyroid Cancer in Children.

Jean-Nicolas Gallant, Vivian L Weiss, Sheau-Chiann Chen, Jiancong Liang, Ryan H Belcher, Fei Ye, Hernan Correa, Huiying Wang
Author Information
  1. Jean-Nicolas Gallant: Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA. ORCID
  2. Vivian L Weiss: Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  3. Sheau-Chiann Chen: Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  4. Jiancong Liang: Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  5. Ryan H Belcher: Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA. ORCID
  6. Fei Ye: Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  7. Hernan Correa: Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  8. Huiying Wang: Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Abstract

The association between Hashimoto's thyroiditis (HT) and pediatric thyroid cancer is controversial. Most studies examining this connection have been based on adults, and larger studies in children are lacking. We performed a retrospective study of all sequential pediatric patients who underwent a thyroidectomy for a neoplasm at our institution over a twenty-year period in order to explore the link between HT and pediatric thyroid cancer. A total of 153 patients, median age 16.5 (interquartile range [IQR] 14.2-18.3) years, underwent thyroid surgery for a neoplasm. Patients were mainly female (80%) and White (84%). Median follow-up was 58.6 (IQR 20.7-105.4) months. Thirty-five (23%) patients had HT. Patients who underwent thyroid surgery and had HT were more likely to harbor a malignant neoplasm ( = 0.05); specifically, papillary thyroid carcinoma (PTC, = 0.02). There was a difference in the distribution of HT among the subtypes of PTC ( = 0.03). Despite this, there was no difference in terms of survival between patients with/without HT. In conclusion, children with a thyroid malignancy, specifically, PTC, are more likely to have HT. The association between HT and pediatric PTC appears to be subtype-specific but does not seem to affect patient survival.

Keywords

References

  1. Thyroid. 2022 Sep;32(9):1109-1117 [PMID: 35950619]
  2. Cell. 2011 Mar 4;144(5):646-74 [PMID: 21376230]
  3. Clin Endocrinol (Oxf). 2021 Oct;95(4):638-648 [PMID: 33894068]
  4. Asian J Surg. 2019 Jan;42(1):112-119 [PMID: 29254871]
  5. Oncologist. 2015 Jan;20(1):19-27 [PMID: 25480825]
  6. Cancer. 1988 Nov 1;62(9):1988-93 [PMID: 3167811]
  7. AMA Arch Surg. 1955 Feb;70(2):291-7 [PMID: 13227748]
  8. Lancet. 2005 Jun 11-17;365(9476):2014-23 [PMID: 15950715]
  9. JAMA. 2010 Dec 15;304(23):2611-9 [PMID: 21156949]
  10. Cell. 2000 Jan 7;100(1):57-70 [PMID: 10647931]
  11. Thyroid. 2016 Jan;26(1):1-133 [PMID: 26462967]
  12. Arch Endocrinol Metab. 2017 Mar-Apr;61(2):180-187 [PMID: 28225863]
  13. Laryngoscope. 2022 Aug;132(8):1668-1674 [PMID: 34687456]
  14. J Endocr Soc. 2019 Mar 05;3(4):791-800 [PMID: 30963137]
  15. Endocrine. 2015 Jun;49(2):361-5 [PMID: 25280964]
  16. Pediatrics. 2014 Oct;134(4):e945-55 [PMID: 25201796]
  17. Arch Pediatr Adolesc Med. 2008 Jun;162(6):526-31 [PMID: 18524742]
  18. J Clin Endocrinol Metab. 2013 Aug;98(8):3238-45 [PMID: 23737541]
  19. Endocr Pathol. 2022 Mar;33(1):27-63 [PMID: 35288841]
  20. Thyroid. 2015 Jul;25(7):716-59 [PMID: 25900731]
  21. J Clin Endocrinol Metab. 2014 Sep;99(9):3193-8 [PMID: 24892990]
  22. Front Oncol. 2017 Apr 10;7:53 [PMID: 28443243]
  23. J Pediatr Endocrinol Metab. 2020 Nov 12;33(12):1511-1517 [PMID: 33180046]
  24. Eur J Endocrinol. 2017 Apr;176(4):433-441 [PMID: 28183787]
  25. Autoimmun Rev. 2014 Apr-May;13(4-5):391-7 [PMID: 24434360]
  26. BMJ. 2007 Oct 20;335(7624):806-8 [PMID: 17947786]
  27. J Endocr Soc. 2019 Jan 04;3(3):607-616 [PMID: 30820486]
  28. J Pediatr. 2014 Jun;164(6):1481-5 [PMID: 24630354]
  29. Crit Rev Oncol Hematol. 2015 Apr;94(1):64-73 [PMID: 25577570]
  30. Horm Res Paediatr. 2016;85(3):181-7 [PMID: 26910846]
  31. Cancer Cytopathol. 2019 Apr;127(4):231-239 [PMID: 30768868]
  32. J Pediatr Surg. 2019 Jun;54(6):1226-1232 [PMID: 30879752]
  33. Surgery. 2013 Dec;154(6):1346-52; discussion 1352-3 [PMID: 24238052]
  34. Lancet Diabetes Endocrinol. 2021 Mar;9(3):144-152 [PMID: 33482107]
  35. Cancer. 2020 Oct 1;126(19):4379-4389 [PMID: 32725630]
  36. Eur J Endocrinol. 2015 Dec;173(6):827-33 [PMID: 26369577]
  37. Eur J Endocrinol. 2019 Nov;181(5):539-544 [PMID: 31536967]
  38. JAMA Oncol. 2022 Sep 1;8(9):1323-1327 [PMID: 35679040]
  39. Thyroid. 2004 Nov;14(11):926-32 [PMID: 15671771]
  40. J Pediatr Surg. 2023 Jun 27;: [PMID: 37479570]
  41. Oncotarget. 2017 Jun 27;8(37):62414-62424 [PMID: 28977955]
  42. Cancer Discov. 2022 Jan;12(1):31-46 [PMID: 35022204]
  43. BMC Cancer. 2012 Dec 21;12:610 [PMID: 23256514]

Grants

  1. K12CA090625/NIH HHS
  2. K12 CA090625/NCI NIH HHS
  3. K08 CA240901/NCI NIH HHS
  4. K08CA240901/NIH HHS
  5. R01 CA272875/NCI NIH HHS
  6. R01CA272875/NIH HHS

Word Cloud

Created with Highcharts 10.0.0thyroidHTpediatricpatientsPTCcancerchildrenunderwentneoplasm=0associationHashimoto'sthyroiditisstudiessurgeryPatientslikelyspecificallypapillarycarcinomadifferencesurvivalcontroversialexaminingconnectionbasedadultslargerlackingperformedretrospectivestudysequentialthyroidectomyinstitutiontwenty-yearperiodorderexplorelinktotal153medianage165interquartilerange[IQR]142-183yearsmainlyfemale80%White84%Medianfollow-up586IQR207-1054monthsThirty-five23%harbormalignant0502distributionamongsubtypes03Despitetermswith/withoutconclusionmalignancyappearssubtype-specificseemaffectpatientThyroiditisRiskPapillaryThyroidCancerChildrenHashimoto’snodule

Similar Articles

Cited By